Commonwealth Equity Services’s Ocera Therapeutics OCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
– Sell
-100,000
Closed -$114K – 2756
2017
Q3
$114K Hold
100,000
– – ﹤0.01% 2406
2017
Q2
$116K Buy
+100,000
New +$116K ﹤0.01% 2348

Commonwealth Equity Services's OCRX Position: Q4 2017 in Review

Commonwealth Equity Services sold out of Ocera Therapeutics (OCRX) in Q4 2017, closing a stake of 100,000 shares — an estimated $114K sold.

Commonwealth Equity Services first reported a position in OCRX in Q2 2017 and held it in 2 quarters. The position peaked at $116K in Q2 2017. 0 funds tracked by Wall St. Rank hold OCRX as of Q4 2017.

  • Commonwealth Equity Services reported no remaining Ocera Therapeutics position as of Q4 2017 after selling out during the quarter.
  • Commonwealth Equity Services sold 100,000 Ocera Therapeutics shares in Q4 2017, an estimated $114K.
  • Commonwealth Equity Services first reported a position in Ocera Therapeutics in Q2 2017 and held it in 2 quarters.
  • Commonwealth Equity Services's Ocera Therapeutics position peaked at $116K in Q2 2017.
  • 0 funds tracked by Wall St. Rank held Ocera Therapeutics as of Q4 2017.

Based on Commonwealth Equity Services's 13F filing for Q4 2017, filed 12 Feb 2018.